Ellen James Shares Insights From the World's First DMT Clinical Trial

In this episode, Joy sits down with Ellen James, Director of Research and Development at Small Pharma, a neuro-pharmaceutical company that is currently developing a psychedelic-assisted therapy for the treatment of mental health conditions.

Small Pharma is one of the few psychedelic companies working with DMT, a naturally occurring psychedelic tryptamine found in plants and the brain of mammals. Scientific evidence suggests DMT offers the potential for rapid-acting and long-lasting antidepressant effects. Small Pharma is leading the world's first DMT clinical trial and Ellen tells us all about it!